MetLife Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.69M Sell
37,325
-677
-2% -$85K 0.03% 606
2025
Q1
$5.2M Sell
38,002
-562
-1% -$76.9K 0.03% 593
2024
Q4
$5.9M Buy
38,564
+690
+2% +$106K 0.03% 468
2024
Q3
$7.34M Sell
37,874
-962
-2% -$186K 0.04% 354
2024
Q2
$9M Buy
38,836
+4,926
+15% +$1.14M 0.05% 266
2024
Q1
$7.31M Sell
33,910
-1,248
-4% -$269K 0.05% 322
2023
Q4
$9.1M Sell
35,158
-648
-2% -$168K 0.07% 237
2023
Q3
$9.2M Sell
35,806
-919
-3% -$236K 0.07% 220
2023
Q2
$10.5M Sell
36,725
-423
-1% -$120K 0.08% 203
2023
Q1
$10.3M Sell
37,148
-446
-1% -$124K 0.07% 201
2022
Q4
$10.4M Sell
37,594
-937
-2% -$259K 0.08% 203
2022
Q3
$10.3M Sell
38,531
-907
-2% -$242K 0.09% 187
2022
Q2
$8.04M Sell
39,438
-518
-1% -$106K 0.06% 248
2022
Q1
$8.41M Buy
39,956
+7,501
+23% +$1.58M 0.05% 294
2021
Q4
$7.79M Sell
32,455
-1,206
-4% -$289K 0.06% 249
2021
Q3
$9.53M Sell
33,661
-1,245
-4% -$352K 0.09% 189
2021
Q2
$12.1M Sell
34,906
-1,396
-4% -$483K 0.11% 158
2021
Q1
$10.2M Sell
36,302
-1,069
-3% -$299K 0.09% 171
2020
Q4
$9.15M Sell
37,371
-2,769
-7% -$678K 0.09% 186
2020
Q3
$11.4M Sell
40,140
-2,539
-6% -$720K 0.12% 147
2020
Q2
$11.4M Sell
42,679
-3,833
-8% -$1.03M 0.13% 149
2020
Q1
$14.7M Sell
46,512
-1,423
-3% -$450K 0.2% 99
2019
Q4
$14.2M Sell
47,935
-2,260
-5% -$671K 0.15% 129
2019
Q3
$11.7M Sell
50,195
-3,250
-6% -$757K 0.13% 153
2019
Q2
$12.5M Sell
53,445
-2,472
-4% -$578K 0.13% 140
2019
Q1
$13.2M Sell
55,917
-1,704
-3% -$403K 0.14% 128
2018
Q4
$17.3M Sell
57,621
-980
-2% -$295K 0.21% 89
2018
Q3
$20.7M Sell
58,601
-3,515
-6% -$1.24M 0.21% 84
2018
Q2
$18M Sell
62,116
-1,552
-2% -$450K 0.21% 79
2018
Q1
$17.4M Sell
63,668
-1,751
-3% -$479K 0.21% 92
2017
Q4
$20.8M Buy
+65,419
New +$20.8M 0.24% 77